TNDM — Tandem Diabetes Care Balance Sheet
0.000.00%
- $999.35m
- $998.04m
- $940.20m
Annual balance sheet for Tandem Diabetes Care, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 485 | 624 | 617 | 468 | 438 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 82.2 | 111 | 115 | 106 | 115 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 637 | 812 | 850 | 748 | 724 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 69.8 | 77.9 | 179 | 164 | 163 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 716 | 905 | 1,053 | 953 | 968 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 104 | 132 | 165 | 195 | 247 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 350 | 472 | 613 | 639 | 705 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 366 | 433 | 440 | 314 | 263 |
| Total Liabilities & Shareholders' Equity | 716 | 905 | 1,053 | 953 | 968 |
| Total Common Shares Outstanding |